» Articles » PMID: 15356032

Essential Amino Acid and Carbohydrate Supplementation Ameliorates Muscle Protein Loss in Humans During 28 Days Bedrest

Overview
Specialty Endocrinology
Date 2004 Sep 10
PMID 15356032
Citations 106
Authors
Affiliations
Soon will be listed here.
Abstract

We determined whether essential amino acid and carbohydrate supplementation could offset the catabolic response to prolonged inactivity. Major outcome measures included mixed muscle fractional synthetic rate (FSR), phenylalanine net balance, lean leg mass, and leg extension strength. On d 1 and 28, vastus lateralis muscle biopsies and femoral arterio-venous blood samples were obtained during a primed constant infusion of l-[ring-(2)H(5)]phenylalanine. Net balance and FSR were calculated over 16 h, during which the control group (CON) received a nutritionally mixed meal every 5 h (0830, 1330, and 1830 h). The experimental group (EXP) also consumed 16.5 g essential amino acids and 30 g carbohydrate (1100, 1600, and 2100 h). The dietary regimen was maintained during bedrest. FSR was higher in the EXP group on d 1 (EXP, 0.099 +/- 0.008%/h; CON: 0.075 +/- 0.005%/h) and d 28 (EXP, 0.093 +/- 0.006%/h; CON, 0.055 +/- 0.007%/h). Lean leg mass was maintained throughout bedrest in the EXP group (+0.2 +/- 0.3 kg), but fell in the CON group (-0.4 +/- 0.1 kg). Strength loss was more pronounced in the CON group (EXP, -8.8 +/- 1.4 kg; CON, -17.8 +/- 4.4 kg). Essential amino acid and carbohydrate supplementation may represent a viable intervention for individuals at risk of sarcopenia due to immobility or prolonged bedrest.

Citing Articles

Nutritional Interventions to Attenuate Quadriceps Muscle Deficits following Anterior Cruciate Ligament Injury and Reconstruction.

Smith M, Hoffman N, Jose A, Burke L, Opar D Sports Med. 2025; .

PMID: 39853659 DOI: 10.1007/s40279-025-02174-w.


Dileucine ingestion, but not leucine, increases lower body strength and performance following resistance training: A double-blind, randomized, placebo-controlled trial.

Hagele A, Krieger J, Gaige C, Holley K, Gross K, Iannotti J PLoS One. 2024; 19(12):e0312997.

PMID: 39739679 PMC: 11687731. DOI: 10.1371/journal.pone.0312997.


Acute Sarcopenia: Mechanisms and Management.

Damanti S, Senini E, De Lorenzo R, Merolla A, Santoro S, Festorazzi C Nutrients. 2024; 16(20).

PMID: 39458423 PMC: 11510680. DOI: 10.3390/nu16203428.


Skeletal muscle immobilisation-induced atrophy: mechanistic insights from human studies.

Deane C, Piasecki M, Atherton P Clin Sci (Lond). 2024; 138(12):741-756.

PMID: 38895777 PMC: 11186857. DOI: 10.1042/CS20231198.


An Amino Acid Mixture to Counteract Skeletal Muscle Atrophy: Impact on Mitochondrial Bioenergetics.

Bellanti F, Lo Buglio A, Pannone G, Pedicillo M, De Stefano I, Pignataro A Int J Mol Sci. 2024; 25(11).

PMID: 38892242 PMC: 11173258. DOI: 10.3390/ijms25116056.